A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors
Clinical trial NCT04158336 · COMPLETED
Trial details
- NCT number
- NCT04158336
- Sponsor
- K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2025-05-06
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.